OMNIPOD
LIVE

Serial Number

97555871

Owner

Insulet Corporation

Attorney

Karen Feisthamel

First Use Date

Apr 20, 2023

Filing Date

Aug 19, 2022

Add to watchlist:

No watchlists yet
View on USPTO

OMNIPOD Trademark

Serial Number: 97555871

OMNIPOD is a trademark filed by Insulet Corporation on August 19, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Insulet Corporation (61 trademarks)

9 Oak Park Drive
Bedford, MA 01730

Entity Type: 03

Trademark Details

Filing Date

August 19, 2022

Registration Date

Not Registered

First Use Anywhere

April 20, 2023

First Use in Commerce

April 20, 2023

Published for Opposition

February 21, 2023

Goods & Services

Downloadable software in the nature of applications for mobile phone and smart phones providing information and personal medical data relating to diabetes management, insulin, sugar levels and the related data; Downloadable and recorded software and computer hardware for use in insulin monitoring and tracking blood glucose levels; downloadable and recorded software and computer hardware for use in the acquisition, storage, sharing and analysis of medical and physiological data in the field of diabetes management; Downloadable and recorded software and computer hardware for predicting blood glucose levels and controlling medicament delivery in the field of diabetes management

Interactive medical monitoring, reporting and alert services for infusion pump users for monitoring and managing diabetes; providing a web site for medical professionals and patients featuring medical information and data from devices used for medical monitoring purposes that feed information to the website that is processed, exchanged and accessed in real-time by users

Medical devices, including, drug delivery devices, namely, implantable drug delivery pumps and ports, sold empty, smart delivery devices, sold empty, in the nature of implantable drug delivery pumps and ports for communicating with smart devices for data processing, wearable subcutaneous drug delivery devices, sold empty in the nature of injectors, on-body injectors, all sold empty, diabetes management devices, in the nature of blood glucose meters and glucometers, infusion pumps, infusion pump controllers and component parts and attachments thereof

Filing History

STATEMENT OF USE PROCESSING COMPLETE
Sep 4, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 4, 2025 AITU
USE AMENDMENT FILED
Apr 17, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Apr 17, 2025 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 18, 2024 EXRA
SOU EXTENSION 3 GRANTED
Oct 18, 2024 EX3G
SOU EXTENSION 3 FILED
Oct 18, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Oct 18, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 18, 2024 EXRA
SOU EXTENSION 2 GRANTED
Apr 18, 2024 EX2G
SOU EXTENSION 2 FILED
Apr 18, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 18, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 19, 2023 EXRA
SOU EXTENSION 1 GRANTED
Oct 17, 2023 EX1G
SOU EXTENSION 1 FILED
Oct 17, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 17, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 18, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 21, 2023 NPUB
PUBLISHED FOR OPPOSITION
Feb 21, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 1, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 13, 2023 CNSA
ASSIGNED TO EXAMINER
Jan 11, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 9, 2022 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 8, 2022 NWOS
NEW APPLICATION ENTERED
Aug 23, 2022 NWAP